Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teh-Ying Chou

Showing results (111-120 of 192) with videos related to

Pageof 20
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 31, 2012
Decoy receptor 3 enhances tumor progression via induction of tumor-associated macrophagesShyh-Kuan Tai, Hsin-Chuan Chang, Keng-Li Lan, et al.
Oncology Reports|April 17, 2012
Associated microsatellite alterations in mitochondrial DNA and in TP53 in thoracic esophageal squamous cell carcinomaChen-Sung Lin, Liang-Shun Wang, Shi-Chuan Chang, et al.
Oncotarget|February 14, 2018
Effect of postoperative systemic therapy on pulmonary adenocarcinoma with unexpected pleural spread detected during thoracotomy or thoracoscopyChi-Lu Chiang, Lei-Chi Wang, Hsiang-Ling Ho, et al.
Journal of the Chinese Medical Association : JCMA|August 30, 2011
Giant branching aneurysmal aberrant systemic artery for intralobar pulmonary sequestration: computed tomographic depiction of arterial and bronchial anomalyChi-Wen Chen, Teh-Ying Chou, Yi-Cheng Yeh, et al.
Targeted Oncology|October 22, 2016
Risk of Second Primary Malignancies in Lung Cancer Survivors - The Influence of Different TreatmentsVincent Yi-Fong Su, Chia-Jen Liu, Yuh-Min Chen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 2, 2010
Co-overexpression of cyclooxygenase-2 and microsomal prostaglandin E synthase-1 adversely affects the postoperative survival in non-small cell lung cancerYu-Chung Wu, Li-Jen Su, Hao-Wei Wang, et al.
The Journal of Pathology|September 4, 2010
Oestrogen-induced epithelial-mesenchymal transition of endometrial epithelial cells contributes to the development of adenomyosisYi-Jen Chen, Hsin-Yang Li, Chi-Hung Huang, et al.
American Journal of Respiratory and Critical Care Medicine|August 1, 2009
Decoy receptor 3 levels in peripheral blood predict outcomes of acute respiratory distress syndromeCheng-Yu Chen, Kuang-Yao Yang, Mei-Yu Chen, et al.
Surgery Today|December 25, 2019
Preoperative biopsy and tumor recurrence of stage I adenocarcinoma of the lungChien-Sheng Huang, Po-Kuei Hsu, Chun-Ku Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancerTeh-Ying Chou, Chao-Hua Chiu, Ling-Hui Li, et al.
Pageof 20

Showing results (111-120 of 192) with videos related to

Sort By:
Pageof 20
Journal of Immunology (Baltimore, Md. : 1950)|January 31, 2012
Decoy receptor 3 enhances tumor progression via induction of tumor-associated macrophagesShyh-Kuan Tai, Hsin-Chuan Chang, Keng-Li Lan, et al.
Oncology Reports|April 17, 2012
Associated microsatellite alterations in mitochondrial DNA and in TP53 in thoracic esophageal squamous cell carcinomaChen-Sung Lin, Liang-Shun Wang, Shi-Chuan Chang, et al.
Oncotarget|February 14, 2018
Effect of postoperative systemic therapy on pulmonary adenocarcinoma with unexpected pleural spread detected during thoracotomy or thoracoscopyChi-Lu Chiang, Lei-Chi Wang, Hsiang-Ling Ho, et al.
Journal of the Chinese Medical Association : JCMA|August 30, 2011
Giant branching aneurysmal aberrant systemic artery for intralobar pulmonary sequestration: computed tomographic depiction of arterial and bronchial anomalyChi-Wen Chen, Teh-Ying Chou, Yi-Cheng Yeh, et al.
Targeted Oncology|October 22, 2016
Risk of Second Primary Malignancies in Lung Cancer Survivors - The Influence of Different TreatmentsVincent Yi-Fong Su, Chia-Jen Liu, Yuh-Min Chen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 2, 2010
Co-overexpression of cyclooxygenase-2 and microsomal prostaglandin E synthase-1 adversely affects the postoperative survival in non-small cell lung cancerYu-Chung Wu, Li-Jen Su, Hao-Wei Wang, et al.
The Journal of Pathology|September 4, 2010
Oestrogen-induced epithelial-mesenchymal transition of endometrial epithelial cells contributes to the development of adenomyosisYi-Jen Chen, Hsin-Yang Li, Chi-Hung Huang, et al.
American Journal of Respiratory and Critical Care Medicine|August 1, 2009
Decoy receptor 3 levels in peripheral blood predict outcomes of acute respiratory distress syndromeCheng-Yu Chen, Kuang-Yao Yang, Mei-Yu Chen, et al.
Surgery Today|December 25, 2019
Preoperative biopsy and tumor recurrence of stage I adenocarcinoma of the lungChien-Sheng Huang, Po-Kuei Hsu, Chun-Ku Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancerTeh-Ying Chou, Chao-Hua Chiu, Ling-Hui Li, et al.
Pageof 20